COVID-19 vaccine intentions in Aotearoa New Zealand: Behaviour, risk perceptions, and collective versus individual motivations

Simple item page
dc.citation.volume4
dc.contributor.authorVinnell LJ
dc.contributor.authorBecker JS
dc.contributor.authorDoyle EEH
dc.contributor.authorGray L
dc.coverage.spatialNetherlands
dc.date.accessioned2023-09-11T01:18:22Z
dc.date.accessioned2023-09-21T22:15:17Z
dc.date.available2022-12-15
dc.date.available2023-09-11T01:18:22Z
dc.date.available2023-09-21T22:15:17Z
dc.date.issued2023
dc.date.updated2023-09-11T01:07:04Z
dc.description(c) The Author/sen_US
dc.description.abstractThe global SARS-CoV-2 (COVID-19) pandemic presents a pressing health challenge for all countries, including Aotearoa New Zealand (NZ). As of early 2022, NZ public health measures have reduced impacts of the pandemic, but ongoing efforts to limit illness and fatalities will be significantly aided by widescale uptake of available vaccines including COVID-19 booster doses. Decades of research have established a broad range of demographic, social, cognitive, and behavioural factors which influence peoples’ uptake of vaccinations, including a large amount of research in the last two years focused on COVID-19 vaccination in particular. In this study, we surveyed people in New Zealand (N = 660) in May and June of 2021, at which point the vaccine had been made available to high-risk groups. We explored individual versus collective motivations, finding that people who were hesitant about COVID-19 vaccination scored lower on independent self-construals (how people define themselves) but higher on community identity, weaker but still positive perceived social norms, lower general risk of COVID-19 to New Zealanders and higher vaccine risk for both themselves and others, and lower response-efficacy both for personal and collective benefits. Overall, the findings suggest some benefit of collective over individual appeals, but that generally messaging to encourage vaccination should focus on conveying social norms, risk from COVID-19 broadly, and vaccine safety and efficacy.
dc.format.extent100082-
dc.identifierS2666-6227(22)00049-1
dc.identifierhttps://www.ncbi.nlm.nih.gov/pubmed/36536877
dc.identifier.citationVinnell LJ, Becker JS, Doyle EEH, Gray L. (2023). COVID-19 vaccine intentions in Aotearoa New Zealand: Behaviour, risk perceptions, and collective versus individual motivations.. Curr Res Ecol Soc Psychol. 4. (pp. 100082-).
dc.identifier.doi10.1016/j.cresp.2022.100082
dc.identifier.eissn2666-6227
dc.identifier.elements-typejournal-article
dc.identifier.harvestedMassey_Dark
dc.identifier.issn2666-6227
dc.identifier.urihttp://hdl.handle.net/10179/20141
dc.languageeng
dc.publisherElsevier B.V
dc.relation.isPartOfCurr Res Ecol Soc Psychol
dc.rightsCC BY-NC-ND 4.0en_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.subjectCOVID-19
dc.subjectCollective efficacy
dc.subjectSelf-construals
dc.subjectSocial norms
dc.subjectVaccine intentions
dc.titleCOVID-19 vaccine intentions in Aotearoa New Zealand: Behaviour, risk perceptions, and collective versus individual motivations
dc.typeJournal article
pubs.elements-id458612
pubs.organisational-groupOther
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
458612.pdf
Size:
1.2 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Journal Articles